99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Neonatal immune function and vaccine responses in children born in low-income versus high-income countries

Clinical and Experimental Immunology

Volumn 160, Issue 1, 2010, Pages 42-47

  Van Den Biggelaar, A H J ^a   Holt, P G ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Innate; Maturation; Neonatal; T cell; Vaccination

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; PNEUMOCOCCUS VACCINE;

CELL FUNCTION; COMPARATIVE STUDY; CONFERENCE PAPER; DIPHTHERIA; FEASIBILITY STUDY; HEPATITIS B; HIGH RISK POPULATION; HUMAN; INFLUENZA; INNATE IMMUNITY; LOWEST INCOME GROUP; NONHUMAN; PAPUA NEW GUINEA; PERTUSSIS; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TETANUS; VACCINATION;

ADULT; AUSTRALIA; CHILD; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HUMANS; IMMUNITY, INNATE; IMMUNIZATION SCHEDULE; INFANT, NEWBORN; PAPUA NEW GUINEA; T-LYMPHOCYTES, REGULATORY; VACCINATION; VACCINES;

EID: 77949416141     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04137.x     Document Type: Conference Paper

References (55)

1. Angelone DF, Wessels MR, Coughlin M et al. Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNFalpha production in vitro and in vivo. Pediatr Res 2006; 60:205-9.
2. De Wit D, Tonon S, Olislagers V et al. Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. J Autoimmun 2003; 21:277-81.
3. Yerkovich ST, Wikstrom ME, Suriyaarachchi D et al. Postnatal development of monocyte cytokine responses to bacterial lipopolysaccharide. Pediatr Res 2007; 62:547-52.
4. Aksoy E, Albarani V, Nguyen M et al. Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells. Blood 2007; 109:2887-93.
5. Levy O, Zarember KA, Roy RM et al. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 2004; 173:4627-34.
6. De Wit D, Olislagers V, Goriely S et al. Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 2004; 103:1030-2.
7. Goriely S, Van Lint C, Dadkhah R et al. A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells. J Exp Med 2004; 199:1011-16.
8. Goriely S, Vincart B, Stordeur P et al. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol 2001; 166:2141-6.
9. Langrish CL, Buddle JC, Thrasher AJ et al. Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin Exp Immunol 2002; 128:118-23.
10. Upham JW, Lee PT, Holt BJ et al. Development of interleukin-12-producing capacity throughout childhood. Infect Immun 2002; 70:6583-8.
11. Sun CM, Deriaud E, Leclerc C et al. Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity 2005; 22:467-77.
12. Zhang X, Deriaud E, Jiao X et al. Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J Exp Med 2007; 204:1107-18.
13. Van den Biggelaar AHJ, Prescott SL, Roponen M et al. Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations. J Allergy Clin Immunol 2009; 124:544-50.
14. Ege MJ, Bieli C, Frei R et al. Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J Allergy Clin Immunol 2006; 117:817-23.
15. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007; 119:184-91.
16. Kalliomaki M, Salminen S, Poussa T et al. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:1019-21.
17. Adegnika AA, Kohler C, Agnandji ST et al. Pregnancy-associated malaria affects toll-like receptor ligand-induced cytokine responses in cord blood. J Infect Dis 2008; 198:928-36.
18. Noakes PS, Hale J, Thomas R et al. Maternal smoking is associated with impaired neonatal toll-like-receptor-mediated immune responses. Eur Respir J 2006; 28:721-9.
19. Paul-Clark MJ, McMaster SK, Sorrentino R et al. Toll-like receptor 2 is essential for the sensing of oxidants during inflammation. Am J Respir Crit Care Med 2009; 179:299-306.
20. Paul-Clark MJ, Sorrentino R, Bailey LK et al. Gram-positive and Gram-negative bacteria synergize with oxidants to release CXCL8 from innate immune cells. Mol Med 2008; 14:238-46.
21. Sadeghi K, Berger A, Langgartner M et al. Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 2007; 195:296-302.
22. de Craen AJ, Posthuma D, Remarque EJ et al. Heritability estimates of innate immunity: an extended twin study. Genes Immun 2005; 6:167-70.
23. Greene JA, Moormann AM, Vulule J, Bockarie MJ, Zimmerman PA, Kazura JW. Toll-like receptor polymorphisms in malariaendemic populations. Malar J 2009; 8:50.
24. Ferwerda B, Alonso S, Banahan K et al. Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock. Proc Natl Acad Sci USA 2009; 106:10272-7.
25. Fumagalli M, Pozzoli U, Cagliani R et al. Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. J Exp Med 2009; 206:1395-408.
26. Brustoski K, Moller U, Kramer M et al. IFN-gamma and IL-10 mediate parasite-specific immune responses of cord blood cells induced by pregnancy-associated Plasmodium falciparum malaria. J Immunol 2005; 174:1738-45.
27. Thornton CA, Upham JW, Wikstrom ME et al. Functional maturation of CD4+CD25+CTLA4+CD45RA+ T regulatory cells in human neonatal T cell responses to environmental antigens/allergens. J Immunol 2004; 173:3084-92.
28. White GP, Hollams EM, Yerkovich ST et al. CpG methylation patterns in the IFNgamma promoter in naive T cells: variations during Th1 and Th2 differentiation and between atopics and non-atopics. Pediatr Allergy Immunol 2006; 17:557-64.
29. Schaub B, Liu J, Hoppler S et al. Impairment of T-regulatory cells in cord blood of atopic mothers. J Allergy Clin Immunol 2008; 121:1491-9.
30. Kohler C, Adegnika AA, Van der Linden R et al. Comparison of immunological status of African and European cord blood mononuclear cells. Pediatr Res 2008; 64:631-6.
31. Malhotra I, Ouma J, Wamachi A et al. In utero exposure to helminth and mycobacterial antigens generates cytokine responses similar to that observed in adults. J Clin Invest 1997; 99:1759-66.
32. Malhotra I, Dent A, Mungai P et al. Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya. PLoS Med 2009; 6:e1000116.
33. Malhotra I, Mungai P, Wamachi A et al. Helminth- and bacillus Calmette - Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J Immunol 1999; 162:6843-8.
34. Marchant A, Appay V, Van Der Sande M et al. Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest 2003; 111:1747-55.
35. Vuillermin PJ, Ponsonby AL, Saffery R et al. Microbial exposure, interferon gamma gene demethylation in naive T-cells, and the risk of allergic disease. Allergy 2009; 64:348-53.
36. Godfrey WR, Spoden DJ, Ge YG et al. Cord blood CD4(+) CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 2005; 105:750-8.
37. Fujimaki W, Takahashi N, Ohnuma K et al. Comparative study of regulatory T cell function of human CD25CD4 T cells from thymocytes, cord blood, and adult peripheral blood. Clin Dev Immunol 2008; 2008:305859.
38. Schaub B, Liu J, Schleich I et al. Impairment of T helper and T regulatory cell responses at birth. Allergy 2008; 63:1438-47.
39. Brustoski K, Moller U, Kramer M et al. Reduced cord blood immune effector-cell responsiveness mediated by CD4+ cells induced in utero as a consequence of placental Plasmodium falciparum infection. J Infect Dis 2006; 193:146-54.
40. Liu E, Law HK, Lau YL. BCG promotes cord blood monocytederived dendritic cell maturation with nuclear Rel-B up-regulation and cytosolic I kappa B alpha and beta degradation. Pediatr Res 2003; 54:105-12.
41. O'Brien KL,Wolfson LJ et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009; 374:893-902.
42. Kamboj KK, King CL, Greenspan NS et al. Immunization with Haemophilus influenzae type b-CRM(197) conjugate vaccine elicits a mixed Th1 and Th2 CD(4+) T cell cytokine response that correlates with the isotype of antipolysaccharide antibody. J Infect Dis 2001; 184:931-5.
43. van den Biggelaar AH, Richmond PC, Pomat WS et al. Neonatal pneumococcal conjugate vaccine immunization primes T cells for preferential Th2 cytokine expression: a randomized controlled trial in Papua New Guinea. Vaccine 2009; 27:1340-7.
44. Rowe J, Yerkovich ST, Richmond P et al. Th2-associated local reactions to the acellular diphtheria - tetanus - pertussis vaccine in 4- to 6-year-old children. Infect Immun 2005; 73:8130-5.
45. Halasa NB, O'Shea A, Shi JR et al. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr 2008; 153:327-32.
46. Siegrist CA. Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunization. J Pediatr 2008; 153:305-7.
47. Aaby P, Jensen H, Samb B et al. Differences in female - male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria - tetanus - pertussis and inactivated poliovirus: reanalysis of West African studies. Lancet 2003; 361:2183-8.
48. Aaby P, Jensen H, Rodrigues A et al. Divergent female - male mortality ratios associated with different routine vaccinations among female - male twin pairs. Int J Epidemiol 2004; 33:367-73.
49. Aaby P, Vessari H, Nielsen J et al. Sex differential effects of routine immunizations and childhood survival in rural Malawi. Pediatr Infect Dis J 2006; 25:721-7.
50. Aaby P, Benn CS, Nielsen J, Ravn H. Sex-differential non-specific effects of BCG and DTP in Cebu, the Philippines. Int J Epidemiol 2009; 38:320-3.
51. Veirum JE, Sodemann M, Biai S et al. Routine vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine 2005; 23:1197-204.
52. Lehmann D, Vail J, Firth MJ et al. Benefits of routine immunizations on childhood survival in Tari, Southern Highlands Province, Papua New Guinea. Int J Epidemiol 2005; 34:138-48.
53. Colditz GA, Brewer TF, Berkey CS et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271:698-702.
54. Annus T, Montgomery SM, Riikjarv MA et al. Atopic disorders among Estonian schoolchildren in relation to tuberculin reactivity and the age at BCG vaccination. Allergy 2004; 59:1068-73.
55. Dilli D, Bostanci I, Dallar Y. Do different vaccination regimens for BCG and hepatitis B affect the development of allergic disorders in early childhood? J Asthma 2008; 45:155-9.